Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.

Lammers, T; Subr, V; Peschke, P; Kühnlein, R; Hennink, W E; Ulbrich, K; Kiessling, F; Heilmann, M; Debus, J; Huber, P E; Storm, G

Lammers, T; Subr, V; Peschke, P; Kühnlein, R; Hennink, W E; Ulbrich, K; Kiessling, F; Heilmann, M; Debus, J; Huber, P E; Storm, G.

Affiliation

Lammers T; Department of Innovative Cancer Diagnosis and Therapy, Clinical Cooperation Unit Radiotherapeutic Oncology, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. t.lammers@dkfz.de

Br J Cancer ; 99(6): 900-10, 2008 Sep 16.

Article in En | MEDLINE | ID: mdl-19238631

Subject(s)

Acrylamides/therapeutic use; Diagnostic Imaging; Doxorubicin/therapeutic use; Iodine Radioisotopes/therapeutic use; Nanomedicine; Prostatic Neoplasms/drug therapy; Prostatic Neoplasms/radiotherapy; Acrylamides/pharmacokinetics; Animals; Antimetabolites, Antineoplastic/pharmacokinetics; Antimetabolites, Antineoplastic/therapeutic use; Combined Modality Therapy; Deoxycytidine/analogs & derivatives; Deoxycytidine/pharmacokinetics; Deoxycytidine/therapeutic use; Doxorubicin/pharmacokinetics; Drug Delivery Systems; Drug Resistance, Neoplasm; Gadolinium; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Prostatic Neoplasms/diagnosis; Radiation Tolerance; Rats; Ribonucleotide Reductases/antagonists & inhibitors; Tissue Distribution; Gemcitabine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Acrylamides / Diagnostic Imaging / Doxorubicin / Nanomedicine / Iodine Radioisotopes Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals Language: En Year: 2008 Type: Article

Fulltext

XML

PubMed Links

Search on Google